BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22988451)

  • 1. Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.
    Tian S; Tang J; Liu H; Wang L; Shen J; Li J; Gan Y
    Exp Diabetes Res; 2012; 2012():209567. PubMed ID: 22988451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate.
    Tian S; Gan Y; Li J; Wang L; Shen J; Liu T; Ye T; Liu H; Liu D; Deng Y; Wang W
    J Nephrol; 2011; 24(4):499-506. PubMed ID: 21425119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.
    Yamamoto Y; Maeshima Y; Kitayama H; Kitamura S; Takazawa Y; Sugiyama H; Yamasaki Y; Makino H
    Diabetes; 2004 Jul; 53(7):1831-40. PubMed ID: 15220208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
    Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice.
    Fu J; Wei C; Zhang W; Schlondorff D; Wu J; Cai M; He W; Baron MH; Chuang PY; Liu Z; He JC; Lee K
    Kidney Int; 2018 Aug; 94(2):326-345. PubMed ID: 29861058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal administration of the globular adiponectin gene ameliorates diabetic nephropathy in Wistar rats.
    Yuan F; Liu YH; Liu FY; Peng YM; Tian JW
    Mol Med Rep; 2014 Jun; 9(6):2293-300. PubMed ID: 24718692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.
    Miyazawa T; Zeng F; Wang S; Fan X; Cheng H; Yang H; Bian A; Fogo AB; Harris RC
    Kidney Int; 2013 Dec; 84(6):1176-88. PubMed ID: 23760291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.
    Yang YY; Shi LX; Li JH; Yao LY; Xiang DX
    Mol Med Rep; 2019 Mar; 19(3):2245-2253. PubMed ID: 30664213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell-specific overexpression of endothelial nitric oxide synthase in Ins2Akita mice exacerbates diabetic nephropathy.
    Natarajan M; Habib SL; Reddick RL; Delma CR; Manickam K; Prihoda TJ; Werner SL; Mohan S
    J Diabetes Complications; 2019 Jan; 33(1):23-32. PubMed ID: 30424931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
    PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
    Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
    BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Enhanced Leucine-Rich
    Haku S; Wakui H; Azushima K; Haruhara K; Kinguchi S; Ohki K; Uneda K; Kobayashi R; Matsuda M; Yamaji T; Yamada T; Minegishi S; Ishigami T; Yamashita A; Ohashi K; Tamura K
    Biomed Res Int; 2018; 2018():2817045. PubMed ID: 30515388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
    Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
    Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eNOS deficiency predisposes podocytes to injury in diabetes.
    Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
    J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
    Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H
    Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy.
    Matsubara T; Abe H; Arai H; Nagai K; Mima A; Kanamori H; Sumi E; Takahashi T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Lab Invest; 2006 Apr; 86(4):357-68. PubMed ID: 16482100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist.
    Makino H; Tanaka I; Mukoyama M; Sugawara A; Mori K; Muro S; Suganami T; Yahata K; Ishibashi R; Ohuchida S; Maruyama T; Narumiya S; Nakao K
    J Am Soc Nephrol; 2002 Jul; 13(7):1757-65. PubMed ID: 12089371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injury to the endothelial surface layer induces glomerular hyperfiltration rats with early-stage diabetes.
    Zhang C; Meng Y; Liu Q; Xuan M; Zhang L; Deng B; Zhang K; Liu Z; Lei T
    J Diabetes Res; 2014; 2014():953740. PubMed ID: 24812636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice.
    Cheng H; Wang H; Fan X; Paueksakon P; Harris RC
    Kidney Int; 2012 Dec; 82(11):1176-83. PubMed ID: 22785174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.